The expression of these NONO-TFE3 and PSPC1 co-downregulated genes (n = 403) was also significantly upregulated in tRCC patients, as indicated by previously published data41 (Fig. 5c). The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.